Clin Psychopharmacol Neurosci.
2017 Aug;15(3):288-291. 10.9758/cpn.2017.15.3.288.
Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report
- Affiliations
-
- 1Department of Psychiatry, Catholic University of Daegu School of Medicine, Daegu, Korea.
- 2Department of Psychiatry, Kyungpook National University School of Medicine, Daegu, Korea. woojm3@hanmail.net
- KMID: 2388278
- DOI: http://doi.org/10.9758/cpn.2017.15.3.288
Abstract
- Long-acting injectable (LAI) antipsychotics are useful in the treatments for schizophrenic patients with poor adherence due to their maintaining feature of therapeutic plasma level without daily administrations. However, their long-lasting property can cause complicated problems such as a long-lasting side effect. We report a patient who experienced LAI-induced extrapyramidal symptoms (EPSs) for 5 months after a single injection. During that period, every trial to ameliorate this condition turned out to be a failure. The 3-month formulation of paliperidone palmitate is now close at hand. We have to be aware of possible long-lasting adverse events and confirm the tolerability to LAI before use.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Ileus in a Patient with Schizophrenia Under Paliperidone Palmitate Treatment
- Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report
- The Drug Adherence and Treatment Effect of the Paliperidone Long Acting Injection
- Safety and Effectiveness of Long Acting Injectable Antipsychotic Paliperidone Palmitate Treatment in Schizophrenics : A 24-Week Open-Label Study
- Change in Cognitive Function after Antipsychotics Treatment : A Pilot Study of Long-Acting Injectable versus Oral Form
